250 related articles for article (PubMed ID: 31192780)
1. Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities.
Keasling AW; Pandey P; Doerksen RJ; Pedrino GR; Costa EA; da Cunha LC; Zjawiony JK; Fajemiroye JO
J Psychopharmacol; 2019 Jul; 33(7):865-881. PubMed ID: 31192780
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.
Perlikowska R; Piekielna J; Mazur M; Koralewski R; Olczak J; do Rego JC; Fichna J; Modranka J; Janecki T; Janecka A
Bioorg Med Chem; 2014 Sep; 22(17):4803-9. PubMed ID: 25047937
[TBL] [Abstract][Full Text] [Related]
3. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
4. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
[TBL] [Abstract][Full Text] [Related]
5. In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice.
Higgs J; Wasowski C; Loscalzo LM; Marder M
Neuropharmacology; 2013 Sep; 72():9-19. PubMed ID: 23624290
[TBL] [Abstract][Full Text] [Related]
6. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
7. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
8. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
9. The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice.
Wang Q; Long Y; Hang A; Zan GY; Shu XH; Wang YJ; Liu JG
Psychopharmacology (Berl); 2016 Jun; 233(12):2411-8. PubMed ID: 27113225
[TBL] [Abstract][Full Text] [Related]
10. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice.
Almatroudi A; Ostovar M; Bailey CP; Husbands SM; Bailey SJ
Br J Pharmacol; 2018 Jul; 175(14):2869-2880. PubMed ID: 28967123
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive activities and mechanism of action of Cepharanthine.
Wei XY; Long JD; Chai JR; Chen J; Gao JP; Wang YJ; Liu JG
Biochem Biophys Res Commun; 2022 Jul; 614():219-224. PubMed ID: 35636221
[TBL] [Abstract][Full Text] [Related]
15. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
18. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
[TBL] [Abstract][Full Text] [Related]
19. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.
Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW
J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657
[TBL] [Abstract][Full Text] [Related]
20. 22-azidosalvinorin A exhibits antidepressant-like effect in mice.
Fajemiroye JO; Prabhakar PR; Cunha LC; Costa EA; Zjawiony JK
Eur J Pharmacol; 2017 Apr; 800():96-106. PubMed ID: 28219707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
